Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection
Glioblastoma (GBM) is a highly malignant tumor of the central nervous system that remains intractable despite advancements in current tumor treatment modalities, including immunotherapy. In recent years, metabolic checkpoints (aberrant metabolic pathways underlying the immunosuppressive tumor microe...
Saved in:
| Main Authors: | Wenhao Li, Zhihao Wang, Siliang Chen, Mingrong Zuo, Yufan Xiang, Yunbo Yuan, Yuze He, Shuxin Zhang, Yanhui Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1462424/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01) -
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
by: Antonio Omuro
Published: (2022-08-01) -
Immunotherapy against glioblastoma using backpack‐activated neutrophils
by: Tatsuya Fukuta, et al.
Published: (2025-01-01) -
Advances in Cellular Immune Theranostic Approaches for Glioblastoma: Current Trends and Future Directions
by: Ying Gong, et al.
Published: (2025-08-01) -
Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma
by: Ligia Gabriela Tataranu
Published: (2025-04-01)